Work

Abstract OT1-1-01: A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs12-ot1-1-01

Authors: A Hirano, A Hattori, M Kamimura, K Ogura, N Kim, Y Setoguchi, F Okubo, H Inoue, N Jibiki, R Miyamoto, J Kinoshita, K Kimura, M Fujibayashi, T Shimizu

Institutions: Tokyo Women's Medical University, Tokyo Women's Medical University Yachiyo Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2056561047

Cites:

Cited by:

Related to: 10